Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Jul 2020 15:00

RNS Number : 7682T
AstraZeneca PLC
22 July 2020
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

AstraZeneca PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

Wellington Management Group LLP

City and country of registered office (if applicable)

Boston, USA

4. Full name of shareholder(s)  (if different from 3)

Name

Bank of New York (Nominees) Ltd

BBH ISL NOMINEES LTD

BNY (OCS) Nominees Limited

BNY Mellon Nominees Limited

GOLDMAN SACHS INTERNATIONAL

HSBC Global Custody Nominee (UK) Limited

Japan Trustee Services Bank Ltd.

JP Morgan Chase Nominees Limited

Mellon Nominees (UK) Ltd.

Nortrust Nominees Limited

ROY Nominees Limited

State Street Nominees Limited

VIDACOS NOMINEES LIMITED

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

20/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

21/07/2020

7. Total positions of person(s) subject to the notification obligation:

% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

2.95%

2.01%

4.96%

1,312,271,081

Position of previous notification (if applicable)

2.97%

2.04%

5.01%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0009895292 Ordinary Shares

38,725,550

2.95%

SUBTOTAL 8.A

38,725,550

2.95%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Depository Receipt

51,934,556 Depository Receipt shares or 25,967,241 votes on a converted basis

1.98%

SUBTOTAL 8.B.1

25,967,241

1.98%

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity Swap

29/01/2021

03/02/2020to29/01/2021

Cash settlement

183,970 Equity Swap shares or 91,985 votes on a converted basis

0.01%

Equity Swap

31/12/2020

05/12/2019to31/12/2020

Cash settlement

140,896 Equity Swap shares or 70,448 votes on a converted basis

0.01%

Equity Swap

30/04/2021

04/05/2020to30/04/2021

Cash settlement

57,837 Equity Swap shares or 28,918 votes on a converted basis

0.00%

Equity Swap

30/06/2021

02/07/2020to30/06/2021

Cash settlement

56,143 Equity Swap shares or 28,071 votes on a converted basis

0.00%

Equity Swap

31/03/2021

02/04/2020to31/03/2021

Cash settlement

55,558 Equity Swap shares or 27,779 votes on a converted basis

0.00%

Equity Swap

31/08/2020

08/08/2019to31/08/2020

Cash settlement

42,723 Equity Swap shares or 21,361 votes on a converted basis

0.00%

Equity Swap

15/05/2023

09/08/2018to15/05/2023

Cash settlement

19,846 Equity Swap shares or 19,846 votes on a converted basis

0.00%

Equity Swap

15/05/2023

20/02/2019to15/05/2023

Cash settlement

35,896 Equity Swap shares or 17,948 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/03/2018to15/05/2023

Cash settlement

11,419 Equity Swap shares or 11,419 votes on a converted basis

0.00%

Equity Swap

15/05/2023

10/10/2017to15/05/2023

Cash settlement

8,928 Equity Swap shares or 8,928 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/10/2018to22/05/2023

Cash settlement

7,796 Equity Swap shares or 7,796 votes on a converted basis

0.00%

Index Future

20/07/2020

01/01/1900to20/07/2020

Cash settlement

1,394 Index Future shares or 7,186 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/10/2018to22/05/2023

Cash settlement

6,487 Equity Swap shares or 6,487 votes on a converted basis

0.00%

Equity Swap

15/05/2023

09/02/2018to15/05/2023

Cash settlement

6,300 Equity Swap shares or 6,300 votes on a converted basis

0.00%

Equity Swap

22/05/2023

15/07/2019to22/05/2023

Cash settlement

6,212 Equity Swap shares or 6,212 votes on a converted basis

0.00%

Equity Swap

22/05/2023

15/06/2020to22/05/2023

Cash settlement

5,919 Equity Swap shares or 5,919 votes on a converted basis

0.00%

Equity Swap

22/05/2023

23/08/2019to22/05/2023

Cash settlement

4,413 Equity Swap shares or 4,413 votes on a converted basis

0.00%

Equity Swap

05/05/2023

03/06/2020to05/05/2023

Cash settlement

3,967 Equity Swap shares or 3,967 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/02/2018to15/05/2023

Cash settlement

3,782 Equity Swap shares or 3,782 votes on a converted basis

0.00%

Equity Swap

22/05/2023

03/07/2018to22/05/2023

Cash settlement

3,496 Equity Swap shares or 3,496 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/01/2020to22/05/2023

Cash settlement

3,382 Equity Swap shares or 3,382 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/01/2019to22/05/2023

Cash settlement

3,207 Equity Swap shares or 3,207 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/04/2018to22/05/2023

Cash settlement

2,982 Equity Swap shares or 2,982 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/07/2018to15/05/2023

Cash settlement

2,827 Equity Swap shares or 2,827 votes on a converted basis

0.00%

Equity Swap

15/05/2023

23/10/2017to15/05/2023

Cash settlement

2,779 Equity Swap shares or 2,779 votes on a converted basis

0.00%

Equity Swap

05/05/2023

20/08/2019to05/05/2023

Cash settlement

5,393 Equity Swap shares or 2,696 votes on a converted basis

0.00%

Equity Swap

22/05/2023

02/06/2020to22/05/2023

Cash settlement

4,154 Equity Swap shares or 2,077 votes on a converted basis

0.00%

Equity Swap

15/05/2023

28/05/2020to15/05/2023

Cash settlement

3,963 Equity Swap shares or 1,981 votes on a converted basis

0.00%

Equity Swap

22/05/2023

10/07/2020to22/05/2023

Cash settlement

1,830 Equity Swap shares or 1,830 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/07/2018to15/05/2023

Cash settlement

1,776 Equity Swap shares or 1,776 votes on a converted basis

0.00%

Equity Swap

22/05/2023

14/04/2020to22/05/2023

Cash settlement

3,326 Equity Swap shares or 1,663 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/06/2020to22/05/2023

Cash settlement

1,570 Equity Swap shares or 1,570 votes on a converted basis

0.00%

Equity Swap

15/05/2023

26/06/2020to15/05/2023

Cash settlement

2,796 Equity Swap shares or 1,398 votes on a converted basis

0.00%

Equity Swap

15/05/2023

11/06/2018to15/05/2023

Cash settlement

1,367 Equity Swap shares or 1,367 votes on a converted basis

0.00%

Equity Swap

05/05/2023

31/07/2019to05/05/2023

Cash settlement

2,654 Equity Swap shares or 1,327 votes on a converted basis

0.00%

Equity Swap

05/05/2023

12/08/2019to05/05/2023

Cash settlement

1,926 Equity Swap shares or 963 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/06/2020to22/05/2023

Cash settlement

1,841 Equity Swap shares or 920 votes on a converted basis

0.00%

Equity Swap

15/05/2023

08/10/2019to15/05/2023

Cash settlement

1,721 Equity Swap shares or 860 votes on a converted basis

0.00%

Equity Swap

22/05/2023

20/01/2020to22/05/2023

Cash settlement

829 Equity Swap shares or 829 votes on a converted basis

0.00%

Equity Swap

15/05/2023

14/06/2019to15/05/2023

Cash settlement

1,593 Equity Swap shares or 796 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/07/2020to22/05/2023

Cash settlement

1,587 Equity Swap shares or 793 votes on a converted basis

0.00%

Equity Swap

05/05/2023

14/07/2020to05/05/2023

Cash settlement

1,504 Equity Swap shares or 752 votes on a converted basis

0.00%

Equity Swap

22/05/2023

13/05/2020to22/05/2023

Cash settlement

1,308 Equity Swap shares or 654 votes on a converted basis

0.00%

Equity Swap

22/05/2023

01/11/2019to22/05/2023

Cash settlement

1,308 Equity Swap shares or 654 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/05/2019to15/05/2023

Cash settlement

1,290 Equity Swap shares or 645 votes on a converted basis

0.00%

Equity Swap

15/05/2023

27/07/2018to15/05/2023

Cash settlement

600 Equity Swap shares or 600 votes on a converted basis

0.00%

Equity Swap

15/05/2023

29/06/2020to15/05/2023

Cash settlement

1,128 Equity Swap shares or 564 votes on a converted basis

0.00%

Equity Swap

15/05/2023

31/03/2020to15/05/2023

Cash settlement

1,052 Equity Swap shares or 526 votes on a converted basis

0.00%

Equity Swap

05/05/2023

03/02/2020to05/05/2023

Cash settlement

1,037 Equity Swap shares or 518 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/01/2020to22/05/2023

Cash settlement

516 Equity Swap shares or 516 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/10/2018to22/05/2023

Cash settlement

486 Equity Swap shares or 486 votes on a converted basis

0.00%

Equity Swap

05/05/2023

15/08/2019to05/05/2023

Cash settlement

841 Equity Swap shares or 420 votes on a converted basis

0.00%

Equity Swap

05/05/2023

13/08/2019to05/05/2023

Cash settlement

834 Equity Swap shares or 417 votes on a converted basis

0.00%

Equity Swap

05/05/2023

02/08/2019to05/05/2023

Cash settlement

818 Equity Swap shares or 409 votes on a converted basis

0.00%

Equity Swap

15/05/2023

26/07/2019to15/05/2023

Cash settlement

647 Equity Swap shares or 323 votes on a converted basis

0.00%

Equity Swap

22/05/2023

03/10/2019to22/05/2023

Cash settlement

162 Equity Swap shares or 162 votes on a converted basis

0.00%

Equity Swap

22/05/2023

21/04/2020to22/05/2023

Cash settlement

131 Equity Swap shares or 131 votes on a converted basis

0.00%

Equity Swap

05/05/2023

13/09/2019to05/05/2023

Cash settlement

40 Equity Swap shares or 40 votes on a converted basis

0.00%

SUBTOTAL 8.B.2

428,101

0.03%

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Wellington Management Group LLP

Wellington Group Holdings LLP

Wellington Investment Advisors Holdings LLP

Wellington Management Company LLP

Wellington Management Group LLP

Wellington Group Holdings LLP

Wellington Investment Advisors Holdings LLP

Wellington Management Global Holdings, Ltd.

Wellington Management International Ltd

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information:

 

 

Place of completion

London

Date of completion

21/07/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLGCGDRXUDDGGD
Date   Source Headline
27th Mar 20197:00 amRNSForxiga approved in Japan for type-1 diabetes
25th Mar 20197:00 amRNSForxiga approved in Europe for type-1 diabetes
18th Mar 20197:00 amRNSUS FDA grants saracatinib ODD for IPF
14th Mar 201912:00 pmRNSNotice of AGM
12th Mar 201912:00 pmRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSFiling of Form 20-F with SEC
5th Mar 201911:00 amRNSAnnual Financial Report
4th Mar 20194:04 pmRNSHolding(s) in Company
1st Mar 20193:00 pmRNSTotal Voting Rights
1st Mar 20191:45 pmRNSLynparza receives positive EU CHMP opinion
26th Feb 20197:00 amRNSLynparza significantly delayed disease progression
25th Feb 20197:00 amRNSBrilinta's PhIII THEMIS trial met primary endpoint
14th Feb 20197:00 amRNSAstraZeneca Full-Year and Q4 2018 Results
6th Feb 20197:00 amRNSUS FDA grants Fasenra Orphan Drug Designation
5th Feb 20197:05 amRNSUS FDA grants Breakthrough Therapy Designation
5th Feb 20197:00 amRNSEMA grants PRIME eligibility for MEDI8897
1st Feb 20193:00 pmRNSTotal Voting Rights
1st Feb 20191:17 pmRNSForxiga receives positive EU CHMP opinion
25th Jan 20192:00 pmRNSCompletion of divestment of US Synagis rights
7th Jan 20191:00 pmRNSAstraZeneca announces organisational changes
2nd Jan 20193:00 pmRNSTotal Voting Rights
20th Dec 20181:47 pmRNSBevespi Aerosphere approved in the EU for COPD
20th Dec 20187:05 amRNSLynparza meets primary endpoint in SOLO-3 trial
20th Dec 20187:00 amRNSPhase III ROCKIES and OLYMPUS roxadustat trials
19th Dec 20186:31 pmRNSFDA approves Lynparza as 1L maintenance therapy
18th Dec 20189:09 amRNSRoxadustat approved in China for the treatment of
14th Dec 20187:00 amRNSDirectorate Change
7th Dec 20187:00 amRNSUpdate on the Phase III EAGLE trial of Imfinzi
6th Dec 20187:00 amRNSDivestment of rights to Covis completed
4th Dec 20183:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20184:00 pmRNSBlock listing Interim Review
3rd Dec 20184:00 pmRNSTotal Voting Rights
3rd Dec 20187:00 amRNSGrünenthal Agreement for Nexium, Vimovo Completed
26th Nov 20187:00 amRNSUS FDA grants Fasenra ODD for EGPA
16th Nov 20187:00 amRNSAstraZeneca provides update on Phase III MYSTIC
13th Nov 20187:00 amRNSAstraZeneca to divest US Synagis rights to Sobi
12th Nov 20187:05 amRNSUS FDA accepts regulatory submission for Lynparza
12th Nov 20187:00 amRNSFarxiga significantly reduced hospitalisation for
8th Nov 20187:00 amRNSAZN: Year-to-Date and Q3 2018 Results
6th Nov 20187:00 amRNSDivestment of rights to Covis Pharma
1st Nov 20183:00 pmRNSTotal Voting Rights
31st Oct 20189:45 amRNSAdditional financial information-Grünenthal deal
30th Oct 20187:00 amRNSGrünenthal Agreement for rights to Nexium, Vimovo
23rd Oct 20187:00 amRNSAstraZeneca Extends Innate Pharma Collaboration
22nd Oct 20187:00 amRNSLynparza shows 70% reduction in PFS ovarian cancer
19th Oct 20181:09 pmRNSCHMP positive opinion Bevespi Aerosphere
16th Oct 20187:00 amRNSFDA Orphan Drug for Lynparza in pancreatic cancer
1st Oct 20183:00 pmRNSTotal Voting Rights
1st Oct 20187:00 amRNSAtacand Agreement with Cheplapharm Completed
28th Sep 20184:00 pmRNSPrevious Announcement Regarding Appointment Of NED

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.